Psilocybin therapy to reduce depression following a terminal diagnosis
JAAPA November 21, 2023 Elizabeth Boudreau, Krissa Orlowski
At the time this abstract was written, Elizabeth Boudreau was a student in the Medex Northwest PA program at the University of Washington School of Medicine. Krissa Orlowski is a part-time lecturer in the Medex Northwest PA program. The authors have disclosed no potential conflicts of interest, financial or otherwise.
DOI: 10.1097/01.jaa.0000994952.07847.2d (opens in new tab)
Psilocybin
Depression economics
Elixir programming language
Psychotherapist
+1